{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:11:19Z","timestamp":1794262279348,"version":"4.9.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112655","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T11:33:43Z","timestamp":1642678423000},"page":"112655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Roles and mechanisms of puerarin on cardiovascular disease\uff1aA review"],"prefix":"10.1016","volume":"147","author":[{"given":"Zhilin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.biopha.2022.112655_bib1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"GBD 2015 DALYs and HALE Collaborators","year":"2016","journal-title":"Lancet (Lond., Engl.)"},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib4","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events","volume":"12","author":"Squizzato","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1080\/14740338.2016.1238457","article-title":"The risk of cardiovascular side effects with anti-anginal drugs","volume":"15","author":"Rousan","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib6","first-page":"303","article-title":"Use of traditional Chinese medicine in Chinese patients with coronary heart disease","volume":"26","author":"Guo","year":"2013","journal-title":"Biomed. Environ. Sci.: BES"},{"key":"10.1016\/j.biopha.2022.112655_bib7","first-page":"559","article-title":"The Traditional Medicine and Modern Medicine from Natural Products","volume":"21","author":"Yuan","year":"2016"},{"key":"10.1016\/j.biopha.2022.112655_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bioorg.2019.02.046","article-title":"Anti-diabetic potential of Pueraria lobata root extract through promoting insulin signaling by PTP1B inhibition","volume":"87","author":"Sun","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcph.96","article-title":"Radix Puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"53","author":"Zhang","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112655_bib10","doi-asserted-by":"crossref","first-page":"2834650","DOI":"10.1155\/2018\/2834650","article-title":"Efficacy and safety of the injection of the traditional chinese medicine puerarin for the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis of 53 randomized controlled trials","volume":"2018","author":"Xie","year":"2018","journal-title":"Evid. -Based Complement. Altern. Med.: eCAM"},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3892\/etm.2016.3004","article-title":"Puerarin and betahistine treatment of vertebrobasilar ischemia vertigo: a meta-analysis of randomized controlled trials","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"Pt B","key":"10.1016\/j.biopha.2022.112655_bib12","article-title":"Puerarin protects against myocardial ischemia\/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1\/NF-\u03baB pathway","volume":"89","author":"Wang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2022.112655_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109847","article-title":"Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model","volume":"124","author":"Jeon","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112655_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biopha.2018.10.161","article-title":"Puerarin attenuates neurological deficits via Bcl-2\/Bax\/cleaved caspase-3 and Sirt3\/SOD2 apoptotic pathways in subarachnoid hemorrhage mice","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jjcc.2013.06.008","article-title":"Puerarin attenuates pressure overload-induced cardiac hypertrophy","volume":"63","author":"Yuan","year":"2014","journal-title":"J. Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2022.112655_bib16","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jnutbio.2011.05.015","article-title":"Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-\u03b21 expression","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpba.2006.07.013","article-title":"Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata","volume":"43","author":"Cherdshewasart","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.procbio.2009.06.021","article-title":"Modeling and prediction of the mixed-mode retention mechanisms for puerarin and its analogues on n-octylamine modified poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate) monoliths","volume":"44","author":"Lv","year":"2009","journal-title":"Process Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/03639040600559123","article-title":"Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats","volume":"32","author":"Li","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40360-018-0216-3","article-title":"Absolute oral bioavailability and disposition kinetics of puerarin in female rats","volume":"19","author":"Anukunwithaya","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phymed.2008.09.004","article-title":"Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry","volume":"16","author":"Prasain","year":"2009","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00204-012-0874-7","article-title":"UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes","volume":"86","author":"Luo","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2022.112655_bib23","first-page":"1487","article-title":"Upregulation of UDP-Glucuronosyltransferases 1a1 and 1a7 Are Involved in Altered Puerarin Pharmacokinetics in Type II Diabetic Rats","volume":"23","author":"Dong","year":"2018"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.112655_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jchromb.2009.12.002","article-title":"Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats","volume":"878","author":"Luo","year":"2010","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/03639040801973495","article-title":"Enhanced oral bioavailability of puerarin using microemulsion vehicle","volume":"35","author":"Wu","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib26","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/03639045.2018.1449856","article-title":"A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations","volume":"44","author":"Wu","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2022.112655_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopha.2017.02.029","article-title":"RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model","volume":"89","author":"Dong","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112655_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejps.2016.02.015","article-title":"A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration","volume":"88","author":"Xu","year":"2016","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.112655_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jep.2015.01.003","article-title":"Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling","volume":"162","author":"Zhang","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/10717544.2016.1259372","article-title":"Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies","volume":"24","author":"Yi","year":"2017","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/ijms22020928","article-title":"Enhancing the physiochemical properties of puerarin via L-Proline co-crystallization: synthesis, characterization, and dissolution studies of two phases of pharmaceutical co-crystals","volume":"22","author":"Inam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/10837450.2011.653822","article-title":"Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin","volume":"18","author":"Gu","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.biopha.2022.112655_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120002","article-title":"Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia","volume":"591","author":"Ma","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2022.112655_bib34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Circ. Res."},{"issue":"6890","key":"10.1016\/j.biopha.2022.112655_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.biopha.2022.112655_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2022.112655_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2007.04.082","article-title":"Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy","volume":"50","author":"Kubo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2022.112655_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2018.00151","article-title":"Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis","volume":"5","author":"Li","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2022.112655_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1749-6632.1987.tb33025.x","article-title":"Vascular endothelium: nature\u2019s blood-compatible container","volume":"516","author":"Gimbrone","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2022.112655_bib40","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/ATVBAHA.113.302028","article-title":"Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2022.112655_bib41","doi-asserted-by":"crossref","first-page":"15274","DOI":"10.1016\/S0021-9258(19)49528-8","article-title":"Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase","volume":"267","author":"Sessa","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.ATV.0000040223.74255.5A","article-title":"Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE\/inducible NO synthase double-knockout mice","volume":"23","author":"Chen","year":"2003","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.112655_bib43","first-page":"373","article-title":"The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction","volume":"10","author":"Zhang","year":"2008","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.29.945","article-title":"Puerarin induces angiogenesis in myocardium of rat with myocardial infarction","volume":"29","author":"Zhang","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lfs.2006.01.016","article-title":"Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats","volume":"79","author":"Yan","year":"2006","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/FJC.0b013e31829dd961","article-title":"Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions","volume":"62","author":"Cheng","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1139\/cjpp-2013-0322","article-title":"Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS","volume":"92","author":"Bao","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s10753-019-01014-0","article-title":"Puerarin protects against LPS-induced vascular endothelial cell hyperpermeability via preventing downregulation of endothelial cadherin","volume":"42","author":"Deng","year":"2019","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13287-015-0022-4","article-title":"Transplantation of cryopreserved human umbilical cord blood-derived endothelial progenitor cells induces recovery of carotid artery injury in nude rats","volume":"6","author":"Yin","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib50","first-page":"685","article-title":"Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease","volume":"90","author":"Eizawa","year":"2004","journal-title":"Heart (Br. Card. Soc. )"},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1291\/hypres.30.133","article-title":"Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease","volume":"30","author":"Wang","year":"2007","journal-title":"Hypertens. Res.: Off. J. Jpn. Soc. Hypertens."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib52","first-page":"1045","article-title":"Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood","volume":"25","author":"Zhu","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib53","first-page":"3877","article-title":"Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1\/2 Nrf2 signaling pathway","volume":"17","author":"Fu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2012.02.136","article-title":"Effect of shear stress, statins and TNF-\u03b1 on hemostatic genes in human endothelial cells","volume":"420","author":"Bergh","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.biopha.2022.112655_bib56","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112655_bib57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.12659\/MSM.911108","article-title":"Effects of puerarin on clinical parameters, vascular endothelial function, and inflammatory factors in patients with coronary artery disease","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib58","first-page":"E83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.pharep.2016.06.007","article-title":"Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-\u03baB pathway in a rabbit model","volume":"68","author":"Ji","year":"2016","journal-title":"Pharmacol. Rep.: PR"},{"key":"10.1016\/j.biopha.2022.112655_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145354","article-title":"Puerarin alleviates coronary heart disease via suppressing inflammation in a rat model","volume":"771","author":"Zhao","year":"2021","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000264938","article-title":"Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway","volume":"85","author":"Hu","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2022.112655_bib62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopha.2018.05.038","article-title":"Puerarin prevents vascular endothelial injury through suppression of NF-\u03baB activation in LPS-challenged human umbilical vein endothelial cells","volume":"104","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib63","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/jf040231f","article-title":"Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo","volume":"53","author":"Kao","year":"2005","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1734-1140(11)70590-4","article-title":"Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-\u03baB activation in LPS-induced RAW264.7 macrophage cells","volume":"63","author":"Hu","year":"2011","journal-title":"Pharmacol. Rep.: PR"},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1742-7843.2010.00548.x","article-title":"Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris","volume":"107","author":"Yang","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"17","key":"10.1016\/j.biopha.2022.112655_bib66","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1073\/pnas.0508235103","article-title":"Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes","volume":"103","author":"Das","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib67","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.bbadis.2018.04.021","article-title":"ERK5\/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice","volume":"1864","author":"Deng","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2022.112655_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","article-title":"Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease","volume":"74","author":"Alexander","year":"2012","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib69","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/CIRCRESAHA.120.317415","article-title":"Genetic regulation of atherosclerosis-relevant phenotypes in human vascular smooth muscle cells","volume":"127","author":"Aherrahrou","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1139\/O07-064","article-title":"Platelet-derived growth factor BB modulates PCNA protein synthesis partially through the transforming growth factor beta signalling pathway in vascular smooth muscle cells","volume":"85","author":"Pan","year":"2007","journal-title":"Biochem. Cell. Biol. = Biochim. Et. Biol. Cell."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5507\/bp.2013.096","article-title":"The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits","volume":"159","author":"Bao","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky., Olomouc, Czechoslov."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib72","doi-asserted-by":"crossref","first-page":"H3144","DOI":"10.1152\/ajpheart.00327.2006","article-title":"Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein\/MAP kinase\/PI3-kinase\/AKT pathways. American journal of physiology","volume":"291","author":"Hashim","year":"2006","journal-title":"Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000112941","article-title":"Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells","volume":"45","author":"Lee","year":"2008","journal-title":"J. Vasc. Res."},{"issue":"7","key":"10.1016\/j.biopha.2022.112655_bib74","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2011.10.442","article-title":"Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells","volume":"52","author":"Wang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12906-018-2206-9","article-title":"Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway","volume":"18","author":"Wan","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib77","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3892\/etm.2020.9400","article-title":"Puerarin protects vascular smooth muscle cells from oxidized low-density lipoprotein-induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways","volume":"20","author":"Hu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib78","first-page":"89","article-title":"Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1\/2 phosphorylation and PCNA expression","volume":"71","author":"Hu","year":"2016","journal-title":"Die Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/2047487314528461","article-title":"Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians","volume":"22","author":"Rashid","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib81","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.fct.2011.09.007","article-title":"Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats","volume":"49","author":"Liu","year":"2011","journal-title":"Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib82","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bcpt.12245","article-title":"Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK\/c-Jun\/CYP7A1 pathway","volume":"115","author":"Ma","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2022.112655_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4545321","article-title":"Puerarin mitigates diabetic hepatic steatosis and fibrosis by inhibiting tgf-\u03b2signaling pathway activation in type 2 diabetic rats","volume":"2018","author":"Hou","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122925","article-title":"Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice","volume":"10","author":"Zheng","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2022.112655_bib85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biopha.2018.05.024","article-title":"Role of PCSK9 in lipid metabolism and atherosclerosis","volume":"104","author":"Lin","year":"2018","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib86","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1194\/jlr.M020743","article-title":"ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma","volume":"53","author":"Annema","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2022.112655_bib87","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2017.05.055","article-title":"Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages","volume":"811","author":"Li","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib88","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FJC.0000000000000431","article-title":"Puerarin suppresses Na+-K+-ATPase-mediated systemic inflammation and CD36 expression, and alleviates cardiac lipotoxicity in vitro and in vivo","volume":"68","author":"Qin","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112655_bib89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.freeradbiomed.2020.11.011","article-title":"Up-regulation of thioredoxin system by puerarin inhibits lipid uptake in macrophages","volume":"162","author":"Li","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.112655_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111521","article-title":"Puerarin attenuates cadmium-induced hepatic lipid metabolism disorder by inhibiting oxidative stress and inflammation in mice","volume":"222","author":"Wan","year":"2021","journal-title":"J. Inorg. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib91","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet signaling and disease: targeted therapy for thrombosis and other related diseases","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11655-017-2419-7","article-title":"Comparison on anticoagulation and antiplatelet aggregation effects of puerarin with heparin sodium and tirofiban hydrochloride: an in vitro study","volume":"24","author":"Li","year":"2018","journal-title":"Chin. J. Integr. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib93","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1142\/S0192415X06004508","article-title":"Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats","volume":"34","author":"Liu","year":"2006","journal-title":"Am. J. Chin. Med."},{"issue":"Suppl 2(Suppl 2)","key":"10.1016\/j.biopha.2022.112655_bib94","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.thromres.2012.02.026","article-title":"Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque","volume":"129","author":"Owens","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2022.112655_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.10.018","article-title":"Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K\/Akt\/eNOS pathway and inhibiting activation of ERK1\/2 and NF-\u03baB","volume":"191","author":"Deng","year":"2017","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.112655_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ehjqcco\/qcaa076","article-title":"Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the global Burden of Disease Study 2017","volume":"8","author":"Dai","year":"2020","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes, qcaa076. Adv. Online Publ."},{"issue":"9932","key":"10.1016\/j.biopha.2022.112655_bib98","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2022.112655_bib99","doi-asserted-by":"crossref","first-page":"30208","DOI":"10.1038\/srep30208","article-title":"Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0008-6363(98)00252-1","article-title":"Myocardial ischaemia and the cardiac nervous system","volume":"41","author":"Armour","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib102","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.neuint.2010.04.010","article-title":"Increased sympathoexcitatory reflex induced by myocardial ischemic nociceptive signaling via P2X2\/3 receptor in rat superior cervical ganglia","volume":"56","author":"Li","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2022.112655_bib103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2014.01.001","article-title":"Puerarin blocks the signaling transmission mediated by P2X3 in SG and DRG to relieve myocardial ischemic damage","volume":"101","author":"Liu","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2022.112655_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2014.03.004","article-title":"Puerarin alleviates aggravated sympathoexcitatory response induced by myocardial ischemia via regulating P2X3 receptor in rat superior cervical ganglia","volume":"70","author":"Liu","year":"2014","journal-title":"Neurochem. Int."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib105","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3390\/molecules23123322","article-title":"Cardioprotective Effects of Puerarin-V on Isoproterenol-Induced Myocardial Infarction Mice Ics Associated with Regulation of PPAR-\u03a5\/NF-\u03baB Pathway","volume":"23","author":"Li","year":"2018","journal-title":"Mol. (Basel, Switz. )"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib106","doi-asserted-by":"crossref","first-page":"17787","DOI":"10.1038\/s41598-020-74246-y","article-title":"The cardioprotective effects of the new crystal form of puerarin in isoproterenol-induced myocardial ischemia rats based on metabolomics","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib107","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrcardio.2009.103","article-title":"Targeting angiogenesis to restore the microcirculation after reperfused MI","volume":"6","author":"van der Laan","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib108","first-page":"20821","article-title":"Puerarin accelerate scardiac angiogenesis and improves cardiac function of myocardial infarction by upregulating VEGFA, Ang-1 and Ang-2 in rats","volume":"8","author":"Ai","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.112655_bib109","first-page":"373","article-title":"The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction","volume":"10","author":"Zhang","year":"2008","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1159\/000354480","article-title":"Effects of puerarin on cardiac differentiation and ventricular specialization of murine embryonic stem cells","volume":"32","author":"Cheng","year":"2013","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib111","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1006\/jmcc.1997.0433","article-title":"Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes","volume":"29","author":"Wobus","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib112","first-page":"7421","article-title":"Puerarin reduces ischemia\/reperfusion-induced myocardial injury in diabetic rats via upregulation of vascular endothelial growth factor A\/angiotensin-1 and suppression of apoptosis","volume":"17","author":"Guo","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib113","first-page":"451","article-title":"Protective effect of puerarin against myocardial reperfusion injury","volume":"105","author":"Fan","year":"1992","journal-title":"Myocard. Metab. Ultrastruct. Chin. Med. J."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib114","first-page":"11","article-title":"The protective effect of puerarin against myocardial reperfusion injury","volume":"105","author":"Fan","year":"1992","journal-title":"Study Card. Funct. Chin. Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cardiores.2006.02.025","article-title":"The role of oxidants and free radicals in reperfusion injury","volume":"70","author":"Zweier","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib116","first-page":"719","article-title":"MicroRNA 21 contributes to the puerarin induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia\/reperfusion injury","volume":"20","author":"Xu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.112655_bib117","doi-asserted-by":"crossref","first-page":"977","DOI":"10.12659\/MSM.897379","article-title":"Puerarin attenuates anoxia\/reoxygenation injury through enhancing bcl-2 associated athanogene 3 expression, a modulator of apoptosis and autophagy","volume":"22","author":"Ma","year":"2016","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib118","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cbf.3026","article-title":"The protective effects of puerarin in cardiomyocytes from anoxia\/reoxygenation injury are mediated by PKC\u03b5","volume":"32","author":"Tang","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib119","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1011335525219","article-title":"Progressively developed myocardial apoptotic cell death during late phase of reperfusion","volume":"6","author":"Zhao","year":"2001","journal-title":"Apoptosis: Int. J. Program. Cell death"},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4196\/kjpp.2021.25.2.147","article-title":"Puerarin pretreatment attenuates cardiomyocyte apoptosis induced by coronary microembolization in rats by activating the PI3K\/Akt\/GSK-3\u03b2 signaling pathway","volume":"25","author":"Chen","year":"2021","journal-title":"Korean J. Physiol. Pharmacol.: Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol."},{"issue":"3 Pt 2","key":"10.1016\/j.biopha.2022.112655_bib121","first-page":"H1145","article-title":"Preconditioning protects ischemic rabbit heart by protein kinase C activation","volume":"266","author":"Ytrehus","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112655_bib122","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1205406","article-title":"Autophagy in human health and disease","volume":"368","author":"Choi","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib123","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib124","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.3892\/mmr.2017.6424","article-title":"Puerarin attenuates myocardial hypoxia\/reoxygenation injury by inhibiting autophagy via the Akt signaling pathway","volume":"15","author":"Tang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.112655_bib125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00441-021-03463-2","article-title":"Puerarin protects cardiomyocytes from ischemia-reperfusion injury by upregulating LncRNA ANRIL and inhibiting autophagy","volume":"385","author":"Han","year":"2021","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib127","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/HYPERTENSIONAHA.106.079426","article-title":"The fuzzy logic of physiological cardiac hypertrophy","volume":"49","author":"Dorn","year":"2007","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib128","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCIMAGING.109.883652","article-title":"A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study","volume":"3","author":"Khouri","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"Jacc. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib130","first-page":"3347","article-title":"Puerarin inhibits apoptosis and inflammation in myocardial cells via PPAR\u03b1 expression in rats with chronic heart failure","volume":"18","author":"He","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib131","first-page":"1195","article-title":"Effects of puerarin on lipopolysaccharide-induced myocardial dysfunction in isolated rat hearts","volume":"30","author":"Shaojun","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib132","doi-asserted-by":"crossref","first-page":"E1104","DOI":"10.1152\/ajpendo.2000.279.5.E1104","article-title":"Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db\/db) mice","volume":"279","author":"Belke","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib133","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbrc.2015.06.067","article-title":"Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction","volume":"463","author":"Cheng","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9970","key":"10.1016\/j.biopha.2022.112655_bib134","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure: the Lancet lecture","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.biopha.2022.112655_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.018","article-title":"Cardiac SERCA2A\/B: therapeutic targets for heart failure","volume":"724","author":"Shareef","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib136","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1159\/000485450","article-title":"Puerarin Enhances Ca2+ Reuptake and Ca2+ Content of Sarcoplasmic Reticulum in Murine Embryonic Stem Cell-Derived Cardiomyocytes via Upregulation of SERCA2a","volume":"44","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib137","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib138","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","article-title":"Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis","volume":"497","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib139","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.201101100","article-title":"The cell biology of disease: cellular mechanisms of cardiomyopathy","volume":"194","author":"Harvey","year":"2011","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.18433\/J3N318","article-title":"Puerarin suppresses angiotensin ii-induced cardiac hypertrophy by inhibiting NADPH oxidase activation and oxidative stress-triggered ap-1 signaling pathways","volume":"18","author":"Gang","year":"2015","journal-title":"J. Pharm. Pharm. Sci.: a Publ. Can. Soc. Pharm. Sci., Soc. Can. Des. Sci. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib141","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/aps.2013.185","article-title":"Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1\/2, p38 and NF-\u03baB pathways","volume":"35","author":"Chen","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112655_bib142","first-page":"1516","article-title":"Puerarin attenuates cardiac hypertrophy partly through increasing mir-15b\/195 expression and suppressing non-canonical transforming growth factor beta (Tgf\u03b2) signal pathway","volume":"22","author":"Zhang","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib143","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2015.07.065","article-title":"Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy","volume":"464","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41401-020-0401-y","article-title":"Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPAR\u03b1\/PGC-1 pathway","volume":"42","author":"Hou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.118.248369","article-title":"Contributions of Nrf2 to puerarin prevention of cardiac hypertrophy and its metabolic enzymes expression in rats","volume":"366","author":"Zhao","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib146","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1142\/S0192415X17500641","article-title":"Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension","volume":"45","author":"Tan","year":"2017","journal-title":"Am. J. Chin. Med."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib147","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","article-title":"Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II","volume":"98","author":"Nakamura","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib148","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib149","doi-asserted-by":"crossref","first-page":"R1014","DOI":"10.1152\/ajpregu.00124.2004","article-title":"Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Regul., Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00210-017-1353-8","article-title":"Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress","volume":"390","author":"Hou","year":"2017","journal-title":"Naunyn-Schmiede \u2019S. Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib151","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib152","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112655_bib153","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.yjmcc.2008.12.024","article-title":"Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy","volume":"46","author":"Villar","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112655_bib154","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jep.2011.10.013","article-title":"Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat","volume":"138","author":"Zhang","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2022.112655_bib155","first-page":"4425","article-title":"Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-\u03b21 (TGF-\u03b21) pathway in myocardial infarction mice","volume":"8","author":"Tao","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2022.112655_bib156","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fphar.2018.00540","article-title":"Nrf2 Is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats","volume":"9","author":"Cai","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112655_bib157","doi-asserted-by":"crossref","first-page":"2647129","DOI":"10.1155\/2017\/2647129","article-title":"Puerarin protects against cardiac fibrosis associated with the inhibition of TGF-\u03b21\/Smad2-mediated endothelial-to-mesenchymal transition","volume":"2017","author":"Jin","year":"2017","journal-title":"PPAR Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib158","first-page":"41","article-title":"Puerarin attenuates angiotensin II-induced cardiac fibroblast proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation","volume":"16","author":"Chen","year":"2018","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2022.112655_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173472","article-title":"Puerarin attenuates the endothelial-mesenchymal transition induced by oxidative stress in human coronary artery endothelial cells through PI3K\/AKT pathway","volume":"886","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0000000000000672","article-title":"Puerarin decreases collagen secretion in angii-induced atrial fibroblasts through inhibiting autophagy via the JNK-Akt-mTOR signaling pathway","volume":"73","author":"Xu","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib161","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12012-020-09571-9","article-title":"Puerarin alleviates lipopolysaccharide-induced myocardial fibrosis by inhibiting PARP-1 to prevent HMGB1-mediated TLR4-NF-\u03baB signaling pathway","volume":"20","author":"Ni","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2022.112655_bib162","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1513\/pats.200605-125SF","article-title":"Smad3 signaling involved in pulmonary fibrosis and emphysema","volume":"3","author":"Gauldie","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"5","key":"10.1016\/j.biopha.2022.112655_bib163","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cas.12630","article-title":"Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-\u03b2 signaling during tumor progression","volume":"106","author":"Saitoh","year":"2015","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib164","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.112655_bib165","article-title":"Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats","volume":"2014","author":"Wu","year":"2014","journal-title":"Evid. -Based Complement. Altern. Med.: eCAM"},{"issue":"7","key":"10.1016\/j.biopha.2022.112655_bib166","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/0735-1097(94)90664-5","article-title":"Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level","volume":"23","author":"Panza","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1 Pt 2","key":"10.1016\/j.biopha.2022.112655_bib167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.HYP.31.1.189","article-title":"Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy","volume":"31","author":"Raij","year":"1998","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib168","first-page":"58","article-title":"Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension","volume":"39","author":"Li","year":"2017","journal-title":"Clin. Exp. Hypertens. (N. Y., N. Y.: 1993)"},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib169","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1142\/S0192415X19500022","article-title":"Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS","volume":"47","author":"Shi","year":"2019","journal-title":"Am. J. Chin. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112655_bib170","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1142\/S0192415X17500641","article-title":"Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension","volume":"45","author":"Tan","year":"2017","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2022.112655_bib171","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.ctm.2020.01.007","article-title":"Endothelial TRPV4 channels and vasodilator reactivity","volume":"85","author":"Chen","year":"2020","journal-title":"Curr. Top. Membr."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib172","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1039\/D0FO02356F","article-title":"Puerarin induces mouse mesenteric vasodilation and ameliorates hypertension involving endothelial TRPV4 channels","volume":"11","author":"Zhou","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2022.112655_bib173","doi-asserted-by":"crossref","unstructured":"Dong, K., Tao, Q.M., Shan, Q.X., Jin, H.F., Pan, G.B., Chen, J.Z., Zhu, J.H., & Xia, Q. (2004). Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta. Conference proceedings:. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 2004, 3757\u20133760. https:\/\/doi.org\/10.1109\/IEMBS.2004.1404054.","DOI":"10.1109\/IEMBS.2004.1404054"},{"issue":"9","key":"10.1016\/j.biopha.2022.112655_bib174","first-page":"787","article-title":"Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes","volume":"112","author":"Qian","year":"1999","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.biopha.2022.112655_bib175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.125567","article-title":"Activation of large-conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarin-mediated vasodilation","volume":"323","author":"Sun","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.112655_bib176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2006.08.078","article-title":"Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery","volume":"552","author":"Yeung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib177","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193369","article-title":"Effect of puerarin on action potential and sodium channel activation in human hypertrophic cardiomyocytes","volume":"40","author":"Lin","year":"2020","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2022.112655_bib178","first-page":"1212","article-title":"Puerarin blocks Na+ current in rat ventricular myocytes","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112655_bib179","doi-asserted-by":"crossref","first-page":"35475","DOI":"10.1038\/srep35475","article-title":"The Effects of Puerarin on Rat Ventricular Myocytes and the Potential Mechanism","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.112655_bib180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11010-011-0746-0","article-title":"Puerarin: a novel antagonist to inward rectifier potassium channel (IK1)","volume":"352","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2022.112655_bib181","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1039\/C8FO01818A","article-title":"The protective role of hawthorn fruit extract against high salt-induced hypertension in Dahl salt-sensitive rats: impact on oxidative stress and metabolic patterns","volume":"10","author":"Zheng","year":"2019","journal-title":"Food Funct."},{"issue":"24","key":"10.1016\/j.biopha.2022.112655_bib182","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms","volume":"69","author":"Hao","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2022.112655_bib183","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tips.2013.09.004","article-title":"Pharmacological tools for the development of traditional Chinese medicine","volume":"34","author":"Liu","year":"2013","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:44:30Z","timestamp":1760100270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":183,"alternative-id":["S0753332222000439"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112655","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles and mechanisms of puerarin on cardiovascular disease\uff1aA review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112655"}}